Arlington Partners’s BlackRock Health Sciences Trust II BMEZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-2,971
Closed -$45.8K 569
2022
Q4
$45.8K Buy
+2,971
New +$46K 0.01% 225

Other funds holding BMEZ

Arlington Partners's BMEZ Position: Q1 2023 in Review

Arlington Partners sold out of BlackRock Health Sciences Trust II (BMEZ) in Q1 2023, closing a stake of 2,971 shares — an estimated $45.8K sold.

Arlington Partners first reported a position in BMEZ in Q4 2022 and held it in 1 quarter. The position peaked at $45.8K in Q4 2022. 85 funds tracked by Wall St. Rank hold BMEZ as of Q1 2023.

  • Arlington Partners reported no remaining BlackRock Health Sciences Trust II position as of Q1 2023 after selling out during the quarter.
  • Arlington Partners sold 2,971 BlackRock Health Sciences Trust II shares in Q1 2023, an estimated $45.8K.
  • Arlington Partners first reported a position in BlackRock Health Sciences Trust II in Q4 2022 and held it in 1 quarter.
  • Arlington Partners's BlackRock Health Sciences Trust II position peaked at $45.8K in Q4 2022.
  • 85 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q1 2023.

Based on Arlington Partners's 13F filing for Q1 2023, filed 26 Apr 2023.